Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 9
Submit an article Journal homepage
84
Views
3
CrossRef citations to date
0
Altmetric
Special Report

High-sensitivity cardiac troponins: no more ‘negatives’

James HP GambleCardiovascular Clinical Research Facility, John Radcliffe Hospital, Oxford OX3 9DU, UKCorrespondence[email protected]
,
Edward W CarltonDepartment of Cardiology, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, Dorset, BH15 2JB, UK
,
William P OrrDepartment of Cardiology, Royal Berkshire NHS Foundation Trust, Craven Road, Reading, Berkshire RG1 5AN, UK
&
Kim GreavesDepartment of Cardiology, Poole Hospital NHS Foundation Trust, Longfleet Road, Poole, Dorset, BH15 2JB, UK
Pages 1129-1139 | Published online: 10 Jan 2014

References

  • Goodacre S, Cross E, Arnold J, Angelini K, Capewell S, Nicholl J. The health care burden of acute chest pain. Heart 91(2), 229–230 (2005).
  • Bhuiya FA, Pitts SR, McCaig LF. Emergency department visits for chest pain and abdominal pain: United States, 1999–2008. NCHS Data Brief 43, 1–8 (2010).
  • Pope JH, Aufderheide TP, Ruthazer R et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N. Engl. J. Med. 342(16), 1163–1170 (2000).
  • Hamm CW, Bassand J-P, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart J. 32(23), 2999–3054 (2011).
  • Greenslade JH, Cullen L, Parsonage W et al. Examining the signs and symptoms experienced by individuals with suspected acute coronary syndrome in the asia-pacific region: a prospective observational study. Ann. Emerg. Med. 60(6), 777–785 (2012).
  • Body R, Carley S, Wibberley C, McDowell G, Ferguson J, Mackway-Jones K. The value of symptoms and signs in the emergent diagnosis of acute coronary syndromes. Resuscitation 81, 281–286 (2010).
  • Body R, McDowell G, Carley S, Mackway-Jones K. Do risk factors for chronic coronary heart disease help diagnose acute myocardial infarction in the Emergency Department? Resuscitation 79(1), 41–45 (2008).
  • Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart 92(7), 987–993 (2006).
  • Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin. Chem. 58(1), 54–61 (2012).
  • Antman E, Bassand J-P, Klein W et al. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J. Am. Coll. Cardiol. 36(3), 959–969 (2000).
  • Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur. Heart J. 33(20), 2551–2567 (2012).
  • Jesse RL. On the relative value of an assay versus that of a test: a history of troponin for the diagnosis of myocardial infarction. J. Am. Coll. Cardiol. 55(19), 2125–2128 (2010).
  • Morrow DA, Cannon CP, Jesse RL et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin. Chem. 53(4), 552–574 (2007).
  • Hwang U, Baumlin K, Berman J et al. Emergency department patient volume and troponin laboratory turnaround time. Acad. Emerg. Med. 17(5), 501–507 (2010).
  • Thygesen K, Mair J, Giannitsis E et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur. Heart J. 33(18), 2252–2257 (2012).
  • Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin. Chem. 56(2), 254–261 (2010).
  • Morrow DA, Antman EM. Evaluation of high-sensitivity assays for cardiac troponin. Clin. Chem. 55(1), 5–8 (2009).
  • Reiter M, Twerenbold R, Reichlin T et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur. Heart J. 32(11), 1379–1389 (2011).
  • Saunders JT, Nambi V, de Lemos JA et al. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the atherosclerosis risk in communities study. Circulation 123, 1367–1376 (2011).
  • Apple FS. A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin. Chem. 55(7), 1303–1306 (2009).
  • Apple FS, Ler R, Murakami MM. Determination of 19 cardiac troponin I and T assay 99th percentile values from a common presumably healthy population. Clin. Chem. 58(11), 1574–1581 (2012).
  • Korley FK, Jaffe AS. Preparing the United States for high-sensitivity cardiac troponin assays. J. Am. Coll. Cardiol. 61(17), 1753–1758 (2013).
  • Body R, Carley S, McDowell G et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity assay. J. Am. Coll. Cardiol. 58(13), 1332–1339 (2011).
  • Keller T, Zeller T, Peetz D et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361(9), 868–877 (2009).
  • Reichlin T, Hochholzer W, Bassetti S et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N. Engl. J. Med. 361(9), 858–867 (2009).
  • Meune C, Drexler B, Haaf P et al. The GRACE score’s performance in predicting in-hospital and 1-year outcome in the era of high-sensitivity cardiac troponin assays and B-type natriuretic peptide. Heart 97(18), 1479–1483 (2011).
  • Antman EM, Cohen M, Bernink PJLM et al. The TIMI risk score for unstable angina/non–st elevation MI. JAMA 284(7), 835–842 (2000).
  • Than M, Cullen L, Reid CM et al. A 2-h diagnostic protocol to assess patients with chest pain symptoms in the Asia-Pacific region (ASPECT): a prospective observational validation study. Lancet 377(9771), 1077–1084 (2011).
  • Than M, Cullen L, Aldous S et al. 2-hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. J. Am. Coll. Cardiol. 59(23), 2091–2098 (2012).
  • Thokala P, Goodacre SW, Collinson PO et al. Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart 98(20), 1498–1503 (2012).
  • Collinson P, Gaze D, Thokala P, Goodacre S. Randomised assessment of treatment using panel assay of cardiac markers-Contemporary Biomarker Evaluation (RATPAC CBE). Health Technol. Assess. 17(15), 1–122 (2013).
  • Gamble JHP, Hutchinson T, Eayrs KE, Orr WP. A rapid chest pain assessment pathway including high-sensitivity troponin T testing reduces length of stay. Heart 99(S2), A18 (2013).
  • Aldous SJ, Richards AM, Cullen L, Than MP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin. Chem. 57(8), 1154–1160 (2011).
  • Braunwald E, Morrow DA. Unstable angina is it time for a requiem? Circulation 127(24), 2452–2457 (2013).
  • Reichlin T, Irfan A, Twerenbold R et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124, 136–145 (2011).
  • Mueller M, Biener M, Vafaie M et al. Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin. Chem. 58(1), 209–218 (2012).
  • Reichlin T, Schindler C, Drexler B et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch. Intern. Med. 172(16), 1211–1218 (2012).
  • Mills NL, Churchhouse AMD, Lee KK et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA 305(12), 1210–1216 (2011).
  • Mueller M, Celik S, Biener M et al. Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome. Clin. Res. Cardiol. 101(10), 837–845 (2012).
  • Van Wijk S, Jacobs L, Eurlings LW et al. Troponin T measurements by high-sensitivity vs conventional assays for risk stratification in acute dyspnea. Clin. Chem. 58(1), 284–292 (2012).
  • Rosjo H, Varpula M, Hagve TA et al. Circulating high sensitivity troponin T in severe sepsis and septic shock: distribution, associated factors, and relation to outcome. Intensive Care Med. 37(1), 77–85 (2011).
  • Weber M, Luchner A, Manfred S et al. Incremental value of high-sensitive troponin T in addition to the revised cardiac index for peri-operative risk stratification in non-cardiac surgery. Eur. Heart J. 34(11), 853–862 (2013).
  • Devereaux PJ, Chan MTV, Alonso-Coello P et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307(21), 2295–2304 (2012).
  • Hoiseth AD, Neukamm A, Karlsson BD, Omland T, Brekke PH, Soyseth V. Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease. Thorax 66(9), 775–781 (2011).
  • Neukamm AMC, Hoiseth AD, Hagve TA, Soyseth V, Omland T. High-sensitivity cardiac troponin T levels are increased in stable COPD. Heart 99(6), 382–387 (2013).
  • Nagarajan V, Hernandez AV, Tang WHW. Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 98(24), 1778–1786 (2012).
  • Van den Bos EJ, Constantinescu AA, van Domburg RT, Akin S, Jordaens LJ, Kofflard MJM. Minor elevations in troponin I are associated with mortality and adverse cardiac events in patients with atrial fibrillation. Eur. Heart J. 32(5), 611–617 (2011).
  • Vélez-Martínez M, Ayers C, Mishkin JD et al. Association of cardiac troponin I with disease severity and outcomes in patients with pulmonary hypertension. Am. J. Cardiol. 111(12), 1812–1817 (2013).
  • Geerse DA, van Berkel M, Vogels S, Kooman JP, Konings CJAM, Scharnhorst V. Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality. Clin. Chem. Lab. Med. 51(6), 1321–1328 (2012).
  • Faiz KW, Thommessen B, Einvik G, Omland T, Ronning OM. Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J. Stroke Cerebrovasc. Dis. doi:10.1016/j.jstrokecerebrovasdis.2013.01.005 (2013) ( Epub ahead of print).
  • Jensen JK, Ueland T, Aukrust P et al. Highly sensitive troponin T in patients with acute ischemic stroke. Eur. Neurol. 68(5), 287–293 (2012).
  • Omland T, Pfeffer MA, Solomon SD et al. Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J. Am. Coll. Cardiol. 61(12), 1240–1249 (2013).
  • Kavsak PA, Xu L, Yusuf S, McQueen MJ. High-sensitivity cardiac troponin I measurement for risk stratification in a stable high-risk population. Clin. Chem. 57(8), 1146–1153 (2011).
  • Saenger AK, Beyrau R, Braun S et al. Multicenter analytical evaluation of a high-sensitivity troponin T assay. Clin. Chim. Acta 412(9–10), 748–754 (2011).
  • Collinson PO, Heung YM, Gaze D et al. Influence of population selection on the 99th percentile reference value for cardiac troponin assays. Clin. Chem. 58(1), 219–225 (2012).
  • Tan KML, Ong L, Loh TP, Saw S, Sethi SK. Application of a high-sensitivity cardiac troponin I assay to a health screen cohort of young asian women and association with cardiovascular risk factors. Clin. Chem. 59(5), 853–854 (2013).
  • Bonaca M, Scirica B, Sabatine M et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J. Am. Coll. Cardiol. 55(19), 2118–2124 (2010).
  • Kelly A-M. Performance of a sensitive troponin assay in the early diagnosis of acute myocardial infarction in the emergency department. Emerg. Med. Australas. 23(2), 181–185 (2011).
  • Aldous SJ, Florkowski CM, Crozier IG, George P, Mackay R, Than M. High sensitivity troponin outperforms contemporary assays in predicting major adverse cardiac events up to two years in patients with chest pain. Ann. Clin. Biochem. 48( Pt 3), 249–255 (2011).
  • Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ 184(5), E260–E268 (2012).
  • Aldous S, Pemberton C, Richards AM, Troughton R, Than M. High-sensitivity troponin T for early rule-out of myocardial infarction in recent onset chest pain. Emerg. Med. J. 29(10), 805–810 (2012).
  • Mills NL, Lee KK, McAllister DA et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ 344, e1533 (2012).
  • Todd J, Freese B, Lu A et al. Ultrasensitive flow-based Immunoassays using single-molecule counting. Clin. Chem. 53(11), 1990–1995 (2007).
  • Omland T, de Lemos JA, Sabatine MS et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361, 2538–2547 (2009).
  • deFilippi CR, de Lemos JA, Christenson RH et al. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. JAMA 304(22), 2494–2502 (2010).
  • De Lemos JA, Drazner MH, Omland T et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 304(22), 2503–2512 (2010).
  • Otsuka T, Kawada T, Ibuki C, Seino Y. Association between high-sensitivity cardiac troponin T levels and the predicted cardiovascular risk in middle-aged men without overt cardiovascular disease. Am. Heart J. 159, 972–978 (2010).
  • Leistner DM, Klotsche J, Pieper L et al. Circulating troponin as measured by a sensitive assay for cardiovascular risk assessment in primary prevention. Clin. Chem. 58(1), 200–208 (2012).
  • Beatty AL KI. HIgh-sensitivity cardiac troponin t levels and secondary events in outpatients with coronary heart disease from the heart and soul study. JAMA Intern. Med. 173(9), 763–769 (2013).
  • Eggers KM, Venge P, Lindahl B, Lind L. Cardiac troponin I levels measured with a high-sensitive assay increase over time and are strong predictors of mortality in an elderly population. J. Am. Coll. Cardiol. 61(18), 1906–1913 (2013).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.